Evidence map›Paper›PMID 39075193›Full record

ArticleScientific reports2024

Extended dipeptide composition framework for accurate identification of anticancer peptides.

Faizan Ullah, Abdu Salam, Muhammad Nadeem, Farhan Amin, Hussain AlSalman, Mohammad Abrar, Taha Alfakih

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Faizan UllahDepartment of Computer Science, Bacha Khan University, Charsadda, 24420, Pakistan.
Abdu SalamDepartment of Computer Science, Abdul Wali Khan University, Mardan, 23200, Pakistan.
Muhammad NadeemDepartment of Computer Science and Software Engineering, International Islamic University, Islamabad, 44000, Pakistan.
Farhan AminSchool of Computer Science and Engineering, Yeungnam University, Gyeongsan, 38541, Korea. farhanamin10@hotmail.com.
Hussain AlSalmanDepartment of Computer Science, College of Computer and Information Sciences, King Saud University, 11543, Riyadh, Saudi Arabia. halsalman@ksu.edu.sa.
Mohammad AbrarFaculty of Computer Studies, Arab Open University, Muscat, Oman.
Taha AlfakihDepartment of Information Systems, College of Computer and Information Sciences, King Saud University, 11543, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of anticancer peptides (ACPs) is crucial, especially in the development of peptide-based cancer therapy. The classical models such as Split Amino Acid Composition (SAAC) and Pseudo Amino Acid Composition (PseAAC) lack the incorporation of feature representation. These advancements improve the predictive accuracy and efficiency of ACP identification. Thus, the effort of this research is to propose and develop an advanced framework based on feature extraction. Thus, to achieve this objective herein we propose an Extended Dipeptide Composition (EDPC) framework. The proposed EDPC framework extends the dipeptide composition by considering the local sequence environment information and reforming the CD-HIT framework to remove noise and redundancy. To measure the accuracy, we have performed several experiments. These experiments were employed using four famous machine learning (ML) algorithms named; Support Vector Machine (SVM), Decision Tree (DT), Random Forest (RF), and K Nearest Neighbor (KNN). For comparisons, we have used accuracy, specificity, sensitivity, precision, recall, and F1-Score as evaluation criteria. The reliability of the proposed framework is further evaluated using statistical significance tests. As a result, the proposed EDPC framework exhibited enhanced performance than SAAC and PseAAC, where the SVM model delivered the highest accuracy of 96. 6% and significant enhancements in specificity, sensitivity, precision, and F1-score over multiple datasets. Due to the incorporation of enhanced feature representation and the incorporation of local and global sequence profiles proposed EDPC achieves higher classification performance. The proposed frameworks can deal with noise and also duplicating features. These are accompanied by a wide range of feature representations. Finally, our proposed framework can be used for clinical applications where ACP identification is essential. Future works will include extending to a larger variety of datasets, incorporating tertiary structural information, and using deep learning techniques to improve the proposed EDPC.

Indexed as

AlgorithmsAntineoplastic AgentsDipeptidesSupport Vector MachineComputational BiologyHumansMachine LearningReproducibility of ResultsAntineoplastic AgentsDipeptidesAnticancer peptidesDisease DiagnosisFeature extractionImage classificationMachine learning

Identifiers

PMID39075193
PMCPMC11286958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.